Navigation Links
BMP Sunstone to Report Third Quarter 2008 Financial Results
Date:11/3/2008

PLYMOUTH MEETING, Pa., Nov. 3 /PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced that it plans to release third quarter 2008 financial results on Monday, November 10, 2008, after the market closes.

The Company will hold a conference call at 9:00 am ET on Tuesday, November 11, 2008, to discuss its fiscal third quarter 2008 results. Listeners may access the call by dialing 1-888-713-4215 or 1-617-213-4867 for international callers, access code: 56085093. Preregistration and a webcast will also be available through the Company's website at http://www.bmpsunstone.com. A replay of the call will be available through November 20, 2008. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 34717463.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses in China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com.

CONTACT

BMP Sunstone Corporation

Fred M. Powell

Chief Financial Officer

610-940-1675

Integrated Corporate Relations, Inc.

Ashley M. Ammon and Christine Duan

203-682-8200 (Investor Relations)


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
2. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
3. BMP Sunstone Announces Official Launch of Ferriprox in PRC
4. BMP Sunstone Announces Participation in June Investor Conferences
5. BMP Sunstone Reports First Quarter 2008 Financial Results
6. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
7. BMP Sunstone Announces Participation in May Investor Conferences
8. BMP Sunstone to Report First Quarter 2008 Financial Results
9. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
10. NxStage Reports Third Quarter 2008 Financial Results
11. World Neurostimulation Market to Reach $5.2 Billion by 2012, According to New Report by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: